Envestnet Asset Management Inc. lessened its stake in shares of Cognex Co. (NASDAQ:CGNX) by 3.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 35,727 shares of the scientific and technical instruments company’s stock after selling 1,286 shares during the period. Envestnet Asset Management Inc.’s holdings in Cognex were worth $3,941,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in CGNX. Daiwa Securities Group Inc. acquired a new position in shares of Cognex in the 2nd quarter valued at $102,000. Huntington National Bank lifted its stake in shares of Cognex by 67.3% in the 3rd quarter. Huntington National Bank now owns 1,367 shares of the scientific and technical instruments company’s stock valued at $151,000 after purchasing an additional 550 shares during the period. IFP Advisors Inc lifted its stake in shares of Cognex by 46.8% in the 2nd quarter. IFP Advisors Inc now owns 1,919 shares of the scientific and technical instruments company’s stock valued at $163,000 after purchasing an additional 612 shares during the period. Bronfman E.L. Rothschild L.P. lifted its stake in shares of Cognex by 2.4% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,999 shares of the scientific and technical instruments company’s stock valued at $170,000 after purchasing an additional 47 shares during the period. Finally, National Planning Corp acquired a new position in shares of Cognex in the 2nd quarter valued at $204,000. 84.25% of the stock is currently owned by institutional investors.

Cognex Co. (CGNX) opened at $63.50 on Tuesday. The firm has a market cap of $11,148.89, a price-to-earnings ratio of 47.51 and a beta of 1.50. Cognex Co. has a 12-month low of $31.18 and a 12-month high of $72.99.

Cognex (NASDAQ:CGNX) last posted its quarterly earnings data on Monday, October 30th. The scientific and technical instruments company reported $0.57 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.05. Cognex had a net margin of 34.77% and a return on equity of 23.31%. The company had revenue of $259.74 million during the quarter, compared to analysts’ expectations of $255.95 million. During the same period in the prior year, the business posted $0.31 earnings per share. The firm’s revenue for the quarter was up 75.6% on a year-over-year basis. research analysts forecast that Cognex Co. will post 1.39 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Friday, December 1st. Stockholders of record on Friday, November 17th were issued a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.28%. The ex-dividend date was Thursday, November 16th. Cognex’s payout ratio is 13.28%.

In other news, Director Patrick Alias sold 5,000 shares of the company’s stock in a transaction on Monday, November 27th. The shares were sold at an average price of $143.54, for a total transaction of $717,700.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Theodor Krantz sold 15,000 shares of the company’s stock in a transaction on Thursday, November 9th. The stock was sold at an average price of $134.05, for a total transaction of $2,010,750.00. Following the sale, the director now directly owns 26,250 shares of the company’s stock, valued at approximately $3,518,812.50. The disclosure for this sale can be found here. Insiders have sold 143,750 shares of company stock valued at $18,540,975 in the last ninety days. Insiders own 5.60% of the company’s stock.

Several equities analysts recently issued reports on the stock. ValuEngine cut shares of Cognex from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. BidaskClub cut shares of Cognex from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. Robert W. Baird boosted their target price on shares of Cognex from $50.00 to $62.00 and gave the company a “neutral” rating in a research note on Tuesday, October 31st. Zacks Investment Research upgraded shares of Cognex from a “hold” rating to a “buy” rating and set a $69.00 target price for the company in a research note on Wednesday, November 1st. Finally, Wolfe Research upgraded shares of Cognex from a “market perform” rating to an “outperform” rating in a research report on Monday, August 14th. Two analysts have rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the stock. Cognex presently has a consensus rating of “Hold” and a consensus price target of $60.17.

TRADEMARK VIOLATION NOTICE: “Cognex Co. (CGNX) Shares Sold by Envestnet Asset Management Inc.” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this news story can be viewed at https://www.watchlistnews.com/cognex-co-cgnx-shares-sold-by-envestnet-asset-management-inc/1758856.html.

About Cognex

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex Co. and related companies with MarketBeat.com's FREE daily email newsletter.